Literature DB >> 27450369

Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria.

Anna Hood1, Jerrel Rutlin2, Joshua S Shimony3, Dorothy K Grange4, Desiree A White5,4.   

Abstract

We tested the hypothesis that brain white matter integrity mediates the relationship between phenylalanine (Phe) control and executive abilities in children with phenylketonuria (PKU; N = 36). To do so, we examined mean diffusivity (MD) from diffusion tensor imaging (DTI) in two white matter brain regions (posterior parietal-occipital, PPO; centrum semiovale, CSO) and lifetime phenylalanine (Phe) exposure; the executive abilities examined included verbal strategic processing, nonverbal strategic processing, and working memory. Mediation modeling showed that MD in the PPO and CSO mediated the relationship between Phe exposure and nonverbal strategic processing, MD in the CSO mediated the relationship between Phe exposure and verbal strategic processing, and MD in the PPO mediated the relationship between Phe exposure and working memory. These exploratory findings demonstrate the importance of using sophisticated modeling procedures to understand the interplay among metabolic control, neural factors, and functional outcomes in individuals with PKU.

Entities:  

Keywords:  Brain; Executive abilities; Mediation; Neuroimaging; Phenylketonuria; White matter

Year:  2016        PMID: 27450369      PMCID: PMC5413446          DOI: 10.1007/8904_2016_579

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  30 in total

1.  Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter.

Authors:  Kenichi Oishi; Karl Zilles; Katrin Amunts; Andreia Faria; Hangyi Jiang; Xin Li; Kazi Akhter; Kegang Hua; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa-Neto; Alan Evans; Jiangyang Zhang; Hao Huang; Michael I Miller; Peter C M van Zijl; John Mazziotta; Susumu Mori
Journal:  Neuroimage       Date:  2008-07-18       Impact factor: 6.556

2.  Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods       Date:  2008-08

3.  Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria.

Authors:  A Rupp; R Kreis; J Zschocke; J Slotboom; C Boesch; D Rating; J Pietz
Journal:  J Cereb Blood Flow Metab       Date:  2001-03       Impact factor: 6.200

Review 4.  Executive function in early-treated phenylketonuria: profile and underlying mechanisms.

Authors:  Shawn E Christ; Stephan C J Huijbregts; Leo M J de Sonneville; Desirée A White
Journal:  Mol Genet Metab       Date:  2010       Impact factor: 4.797

5.  Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria.

Authors:  Huiling Peng; Dawn Peck; Desirée A White; Shawn E Christ
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

6.  Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria.

Authors:  Anna Hood; Jo Ann V Antenor-Dorsey; Jerrel Rutlin; Tamara Hershey; Joshua S Shimony; Robert C McKinstry; Dorothy K Grange; Shawn E Christ; Robert Steiner; Desiree A White
Journal:  Mol Genet Metab       Date:  2014-11-13       Impact factor: 4.797

7.  Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function.

Authors:  Kathryn DeRoche; Marilyn Welsh
Journal:  Dev Neuropsychol       Date:  2008       Impact factor: 2.253

8.  Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion.

Authors:  T Scarabino; T Popolizio; M Tosetti; D Montanaro; G M Giannatempo; R Terlizzi; S Pollice; A Maiorana; N Maggialetti; A Carriero; V Leuzzi; U Salvolini
Journal:  Radiol Med       Date:  2009-03-10       Impact factor: 3.469

9.  White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria.

Authors:  Desirée A White; Jo Ann V Antenor-Dorsey; Dorothy K Grange; Tamara Hershey; Jerrel Rutlin; Joshua S Shimony; Robert C McKinstry; Shawn E Christ
Journal:  Mol Genet Metab       Date:  2013-07-19       Impact factor: 4.797

10.  Apparent diffusion coefficient restriction in the white matter: going beyond acute brain territorial ischemia.

Authors:  Valentina Citton; Alberto Burlina; Claudio Baracchini; Massimo Gallucci; Alessia Catalucci; Sandro Dal Pos; Alessandro Burlina; Renzo Manara
Journal:  Insights Imaging       Date:  2011-12-20
View more
  3 in total

1.  Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism.

Authors:  Andrea L Gropman; Afrouz Anderson
Journal:  J Transl Genet Genom       Date:  2020-11-13

2.  White matter microstructural damage in early treated phenylketonuric patients.

Authors:  María Julieta González; Mónica Rebollo Polo; Pablo Ripollés; Rosa Gassió; Aída Ormazabal; Cristina Sierra; Roser Colomé Roura; Rafael Artuch; Jaume Campistol
Journal:  Orphanet J Rare Dis       Date:  2018-10-26       Impact factor: 4.123

3.  White and gray matter brain development in children and young adults with phenylketonuria.

Authors:  Zoë Hawks; Anna M Hood; Dov B Lerman-Sinkoff; Joshua S Shimony; Jerrel Rutlin; Daniel Lagoni; Dorothy K Grange; Desirée A White
Journal:  Neuroimage Clin       Date:  2019-07-02       Impact factor: 4.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.